
MOLBIO
Molbio Diagnostics Limited
- IPO Status
- Closed
- Open Date
- 10 Aug 2026
- Close Date
- 12 Aug 2026
IPO Details
- Min. Investment
- ₹14,526
- Price Band
- ₹768 - ₹807
- Lot Size
- 18 shares
- Issue Size
- ₹940 Cr
- Face Value
- 1
- IPO Doc
- —
Schedule
- IPO open10 Aug 2026
- IPO close date12 Aug 2026
- Allotment date13 Aug 2026
- Funds unblock or debit14 Aug 2026
- Listing date17 Aug 2026
Financial Performance
- Revenue
- Profit
Stocks similar to MOLBIO
- Poly Medicure Limited
- Dr. Lal Pathlabs Limited
- Metropolis Healthcare Limited
FAQs
Molbio Diagnostics Limited IPO is a Mainboard IPO aggregating up to ₹940 Cr, with equity shares of face value ₹1 each. The shares are proposed to be listed on NSE and BSE.
The Molbio Diagnostics Limited IPO opened on 10 Aug 2026 and closed on 12 Aug 2026. IPO Period: 10 Aug 2026 – 12 Aug 2026.
The price band for the Molbio Diagnostics Limited IPO is ₹768 to ₹807 per share. Investors can bid within the specified price band, subject to the applicable IPO rules.
The minimum lot size is 18 shares. At the upper price band of ₹807, the minimum investment required is ₹14,526.
Particular Details Lot Size 18 shares Price Band ₹768 – ₹807 Minimum Investment ₹14,526 Maximum Retail Lots 13 Here is the timeline for the Molbio Diagnostics Limited IPO:
IPO Event Date IPO Opens 10 Aug 2026 IPO Closes 12 Aug 2026 UPI Mandate Deadline 12 Aug 2026, 5:00 PM Basis of Allotment 13 Aug 2026 Refund Initiation 14 Aug 2026 Shares Credited 14 Aug 2026 Listing Date 17 Aug 2026 The basis of allotment for the Molbio Diagnostics Limited IPO is expected to be finalised on 13 Aug 2026. Investors can check their allotment status through the registrar or relevant stock exchange website using their application details. Registrar: KFin Technologies.
The equity shares of Molbio Diagnostics Limited are proposed to be listed on NSE and BSE. Proposed Listing Date: 17 Aug 2026.
The key financial performance of Molbio Diagnostics Limited is:
Financial Year Revenue Profit FY24 ₹836.56 Cr ₹101.95 Cr FY25 ₹1,020.42 Cr ₹145.1 Cr FY26 ₹1,445.69 Cr ₹166.59 Cr Revenue CAGR: 31.5% | Profit CAGR: 27.8%. Figures are as disclosed in the company's offer documents.


